Covata has entered into a strategic alliance with dataglobal, a German enterprise information management and archiving software company, to gain access to its data classification technology and to work together on cross-selling opportunities. This should accelerate the development of Covata’s data security platform (DSP) as well as offer a new channel through which it can sell its solutions in Europe. Covata will also have the rights to resell dataglobal’s other products globally.
Covata |
Next piece of the jigsaw
|
Software |
QuickView
22 March 2018 |
Share price graph
Share details
Business description
Bull
Bear
Analysts
Covata is a research client of Edison Investment Research Limited |
||||||||||||||||||||||||
Covata has entered into a strategic alliance with dataglobal, a German enterprise information management and archiving software company, to gain access to its data classification technology and to work together on cross-selling opportunities. This should accelerate the development of Covata’s data security platform (DSP) as well as offer a new channel through which it can sell its solutions in Europe. Covata will also have the rights to resell dataglobal’s other products globally.
Strategic alliance with dataglobal
Covata has entered into a strategic alliance with dataglobal, a privately owned German software company, specialising in enterprise information management and archiving, with more than 550 corporate customers across 40 countries. Covata is acquiring access to dataglobal’s data classification IP, which includes an automated data classification engine, connectors into content service platforms and data analysis tools. It will pay €1m over FY18 and FY19 for its own version of the core IP and will also sign up to a maintenance contract to access support from dataglobal.
Accelerating development of the DSP
Covata plans to integrate dataglobal’s data classification IP into its data security platform. Covata already has data discovery (via Cipherpoint) and secure data sharing functionality, and this adds a crucial building block to the platform. Covata expects the integration process to take three to four months, which is a much shorter timescale than if Covata had developed this software in house. The reduction in internal R&D for this element of the platform should offset some of the cost of the IP.
Cross-selling opportunity
As part of the deal, Covata has entered into a worldwide OEM agreement to become a reseller of the full dataglobal product range – this includes data archiving and data storage analysis software. Covata and dataglobal have also agreed to share sales leads and collaborate on channel development.
Tracking the milestones
There are no forecasts available; to track progress we continue to monitor contract wins, half-yearly order intake, cash burn and the development of the DSP. This news confirms that Covata is moving closer to the launch of a complete DSP.
|
Historical financials
Source: Covata |
|
Disclaimer
|
|
Disclaimer
|
Crossject recently reported FY17 results and that it remains on track for regulatory filings for several programmes in 2019, including Zeneo Sumatriptan, Midazolam, Epinephrine/Adrenaline, Hydrocortisone, and Naloxone with Terbutaline and Methotrexate in 2020. A key upcoming catalyst would be a US licensing agreement for Zeneo Sumatriptan for the treatment of acute migraine, which could come in H118.